Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Strenkoski-Nix, LC; Ermer, J; DeCleene, S; Cevallos, W; Mayer, PR
   Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects
   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
   
   L.C. Strenkoski-Nix et al., "Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects", AM J HEAL S, 57(16), 2000, pp. 1499-1505
2. Drover, D; Lemmens, H; Naidu, S; Cevallos, W; Darwish, M; Stanski, D
   Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem
   CLINICAL THERAPEUTICS
   
   D. Drover et al., "Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem", CLIN THER, 22(12), 2000, pp. 1443-1461
3. Danjou, P; Paty, I; Fruncillo, R; Worthington, P; Unruh, M; Cevallos, W; Martin, P
   A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   P. Danjou et al., "A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening", BR J CL PH, 48(3), 1999, pp. 367-374
4. OSMAN M; CHANDRASEKARAN A; CHAN K; SCATINA J; ERMER J; CEVALLOS W; SISENWINE SF
   METABOLIC DISPOSITION OF C-14-BROMFENAC IN HEALTHY MALE-VOLUNTEERS
   Journal of clinical pharmacology
   
   M. Osman et al., "METABOLIC DISPOSITION OF C-14-BROMFENAC IN HEALTHY MALE-VOLUNTEERS", Journal of clinical pharmacology, 38(8), 1998, pp. 744-752